title: Hypocalcaemia after intravenous bisphosphonate: adjuvant bisphosphonate is not currently accepted practice.
authors.forename: Carlo
authors.initials: C
authors.lastname: Palmieri
authors.forename: Tony
authors.initials: T
authors.lastname: Dhillon
authors.forename: Charles
authors.initials: C
authors.lastname: Coombes
authors.forename: David
authors.initials: D
authors.lastname: Vigushin
mesh_terms: D000963:Antimetabolites / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D017024:Chemotherapy, Adjuvant; D004002:Clodronic Acid / Q000627:therapeutic use; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced*; D007262:Infusions, Intravenous
chemical_list: D000963:Antimetabolites; D004164:Diphosphonates; D004002:Clodronic Acid